2,370
Views
32
CrossRef citations to date
0
Altmetric
Editorial

Challenges in drug discovery for overcoming ‘dysfunctional pain’: an emerging category of chronic pain

Bibliography

  • Woolf CJ. What is this thing called pain? J Clin Invest 2010;120(11):3742–4
  • Sarzi-Puttini P, Atzeni F, Di Franco M, et al. Dysfunctional syndromes and fibromyalgia: a 2012 critical digest. Clin Exp Rheumatol 2012;30(6 Suppl 74):143–51
  • Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013;10(1):13–23
  • Häuser W, Walitt B, Fitzcharles MA, Sommer C. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther 2014;16(1):201
  • Hillila MT, Farkkila NJ, Farkkila MA. Societal costs for irritable bowel syndrome – a population based study. Scand J Gastroenterol 2010;45(5):582–91
  • Skaer TL. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics 2014;32(5):457–66
  • Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014;311(15):1547–55
  • Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015;313(9):949–58
  • Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol 2014;175:30–7
  • Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc 2015;90(5):680–92
  • Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil 2012;24(10):895–913
  • Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46(5):1333–43
  • Hampson JP, Reed BD, Clauw DJ, et al. Augmented central pain processing in vulvodynia. J Pain 2013;14(6):579–89
  • McCarberg BH. Clinical overview of fibromyalgia. Am J Ther 2012;19(5):357–68
  • Cuatrecasas G, Alegre C, Fernandez-Solà J, et al. Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain 2012;153(7):1382–9
  • El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. Peptides 2015;67:12–19
  • Napadow V, Kim J, Clauw DJ, Harris RE. Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum 2012;64(7):2398–403
  • Mayer EA, Gupta A, Kilpatrick LA, Hong JY. Imaging brain mechanisms in chronic visceral pain. Pain 2015;156(Suppl 1):S50–63
  • Nascimento SS, Camargo EA, DeSantana JM, et al. Linalool and linalool complexed in β-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia. Naunyn Schmiedebergs Arch Pharmacol 2014;387(10):935–42
  • Botelho MA, Queiroz DB, Barros G, et al. Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study. Clinics (Sao Paulo) 2014;69(2):75–82
  • Moloney RD, O’Mahony SM, Dinan TG, Cryan JF. Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry 2015;6:15
  • DeSantana JM, da Cruz KM, Sluka KA. Animal models of fibromyalgia. Arthritis Res Ther 2013;15(6):222

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.